In the News
The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.
Published: June 23, 2017
A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers at the Perelman School of Medicine at the University ... More >>.
Published: June 06, 2017
New research presented at the American Society of Clinical Oncology 53rd Annual Meeting in Chicago, shows that a previously untested combination of a monoclonal antibody-drug conjugate with a common chemothe ... More >>.
Published: June 01, 2017
Author: Carlos Harrison
A recent study of chronic myeloid leukemia (CML) patient outcomes found a direct and disturbingly high correlation between insurance status at diagnosis and overall survival.
For patients under 65 ye ... More >>.
Published: May 17, 2017
University of Georgia researchers, with colleagues from the University of Tokyo, have identified a new drug target for the two most common types of myeloid leukemia, including a way to turn back the most agg ... More >>.
Published: May 15, 2017
Patients with double hit lymphoma (DHL) who undergo autologous stem-cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission of live longer that patients who do not ... More >>.
Published: May 10, 2017
UT Health San Antonio researchers discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone ... More >>.
Published: April 27, 2017
Author: Andrea Greif
In just the past three years, we've seen a plethora of new therapies approved to treat patients with chronic lymphocytic leukemia and multiple myeloma. And the rapid advancing field of cancer immunotherapy h ... More >>.
Published: April 10, 2017
Author: Megan Garlapow, PhD
Over 70% of all patients with acute myeloid leukemia (AML) are 60 years or older. Worse prognoses tend to characterize this elderly population, due to frailty and comorbidities. Precision medicines have impr ... More >>.
Published: April 05, 2017
The Leukemia & Lymphoma Society (LLS) continues to advance the promising field of immunotherapy research, harnessing the body's own immune system to fight cancer, with a $4 million funding commitment in ... More >>.
Published: April 04, 2017
Author: Lisa A. Thompson, PharmD, BCOP
During the summer, many patients with chronic myeloid lymphoma (CML) who are taking oral chemotherapy drugs have questions about taking their drugs while traveling. There are many things for patients and the ... More >>.